Skip to content

Clinical trials

Trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Country / region: Austria Clear all

7,799 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200034
200150
200280
200397
2004141
2005167
2006243
2007269
2008317
2009307
2010339
2011355
2012351
2013320
2014328
2015327
2016301
2017413
2018376
2019387
2020427
2021450
2022336
2023357
2024345
2025304
2026217

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4,694
Recruiting857
Unknown status709
Terminated684
Active, not recruiting598
Withdrawn91
Not yet recruiting84
Enrolling by invitation45
Suspended17
No longer available11
Approved for marketing7
Temporarily not available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna994
Medical University of Graz433
Novartis Pharmaceuticals250
Hoffmann-La Roche201
Bayer171
Medical University Innsbruck168
Boehringer Ingelheim160
AstraZeneca142
Bristol-Myers Squibb134
Eli Lilly and Company130

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms217
Diabetes Mellitus, Type 2168
Carcinoma, Non-Small-Cell Lung162
Neoplasms156
Diabetes Mellitus133
Heart Failure133
Atrial Fibrillation101
Diabetes Mellitus, Type 1101
Crohn Disease100
Colorectal Neoplasms99

Trials

Showing 51 to 75 of 7,799. Each trial links to its page on Pharma Observatory.

7,699 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.